Red Cell Transfusion in Acute Myocardial Infarction: AABB International Clinical Practice Guidelines.

Area of Science:

• Cardiology
• Transfusion Medicine
• Clinical Guidelines

Background:

• Optimal red blood cell transfusion strategies for acute myocardial infarction (AMI) remain unclear.
• Existing evidence involves randomized controlled trials comparing restrictive and liberal transfusion approaches.
• Patient-centered outcomes, including medical, financial, and psychological effects, are considered alongside healthcare system concerns.

Purpose of the Study:

• To provide evidence-based recommendations for red blood cell transfusion in patients with AMI.
• To guide clinical decision-making regarding transfusion thresholds in the context of AMI.

Main Methods:

• Meta-analysis of randomized controlled trials using Cochrane methods.
• Application of GRADE (Grading of Recommendations Assessment, Development and Evaluation) methodology for evidence synthesis and recommendation formulation.
• Consideration of patient perspectives and healthcare system resource limitations.

Main Results:

• A liberal red cell transfusion strategy is suggested for hospitalized AMI patients with hemoglobin concentration < 10 g/dL (conditional recommendation, low-certainty evidence).
• A restrictive transfusion strategy (7-8 g/dL) may be associated with increased mortality in AMI patients.
• The recommendation for a liberal strategy prioritizes mortality reduction but is conditional due to low evidence certainty and blood supply conservation concerns.

Conclusions:

• Clinicians should consider a liberal transfusion strategy for AMI patients with hemoglobin < 10 g/dL, while mitigating potential adverse events.
• Transfusion decisions should integrate clinical context beyond solely hemoglobin concentration.
• Further research is needed to clarify optimal transfusion thresholds and strategies in AMI.